MCM
REGN icon

Monarch Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Monarch Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Buy
3,816
+611
+19% +$416K 0.55% 51
2026
Q1 		$2.48M Buy
3,205
+86
+3% +$65.8K 0.61% 51
2025
Q4 		$2.41M Buy
3,119
+204
+7% +$139K 0.59% 49
2025
Q3 		$1.64M Buy
2,915
+570
+24% +$322K 0.4% 62
2025
Q2 		$1.23M Buy
2,345
+941
+67% +$525K 0.33% 66
2025
Q1 		$890K Buy
1,404
+337
+32% +$232K 0.25% 69
2024
Q4 		$760K Buy
1,067
+549
+106% +$461K 0.21% 75
2024
Q3 		$545K Sell
518
-46
-8% -$51.2K 0.15% 88
2024
Q2 		$593K Sell
564
-20
-3% -$19.4K 0.17% 84
2024
Q1 		$562K Hold
584
– – 0.16% 84
2023
Q4 		$513K Sell
584
-29
-5% -$23.9K 0.16% 84
2023
Q3 		$504K Sell
613
-20
-3% -$15.7K 0.16% 84
2023
Q2 		$455K Sell
633
-15
-2% -$11.6K 0.14% 91
2023
Q1 		$532K Hold
648
– – 0.16% 80
2022
Q4 		$468K Sell
648
-3
-0.5% -$2.21K 0.14% 87
2022
Q3 		$448K Sell
651
-33
-5% -$20.8K 0.15% 85
2022
Q2 		$404K Sell
684
-5
-0.7% -$3.25K 0.12% 93
2022
Q1 		$481K Buy
689
+210
+44% +$133K 0.13% 90
2021
Q4 		$302K Buy
+479
New +$295K 0.08% 103

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Monarch Capital Management's REGN Position: Q2 2026 in Review

Monarch Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 19% in Q2 2026, buying an estimated $416K and bringing the position to 3,816 shares worth $2.38M. The position accounts for 0.55% of the portfolio, ranked #51.

Monarch Capital Management first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.48M in Q1 2026. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Monarch Capital Management held 3,816 shares of Regeneron Pharmaceuticals worth $2.38M as of Q2 2026.
  • Monarch Capital Management bought 611 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $416K.
  • Regeneron Pharmaceuticals made up 0.55% of Monarch Capital Management's portfolio in Q2 2026, its #51 holding.
  • Monarch Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Monarch Capital Management's Regeneron Pharmaceuticals position peaked at $2.48M in Q1 2026.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.